×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Monte Rosa Therapeutics Inc. (GLUE) NASDAQ

$7.04 0.45 (6.83%)

Market Cap: $353.08M

As of 03/27/24 04:00 PM EDT. Market closed.

(GLUE)

Monte Rosa Therapeutics Inc. (GLUE)
NASDAQ

$7.04
0.45 (6.83%)

Market Cap: $353.08M

As of 03/27/24 04:00 PM EDT. Market closed.

Add to Portfolio

small molecule protein degraders are set to reshape the way by which diseases will be treated. our rational approach in targeting disease-causing proteins for degradation will deliver pioneering therapies for cancer and beyond. headquartered in boston with additional laboratory facilities in basel, monte rosa therapeutics is a private company launched in 2020. initially seeded by versant ... read more

small molecule protein degraders are set to reshape the way by which diseases will be treated. our rational approach in targeting disease-causing proteins for degradation will deliver pioneering therapies for cancer and beyond. headquartered in boston with additional laboratory facilities in basel, monte rosa therapeutics is a private company launched in 2020. initially seeded by versant ventures and incubated at ridgeline discovery in basel, and the institute of cancer research in london, monte rosa has raised $32.5 million from versant and new enterprise associates. academic co-founders are prof. raj chopra and prof. ian collins of the institute for cancer research, uk. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Full Time Employees
123
Address
.
PRICE CHART FOR MONTE ROSA THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$6.59
Days Range
$6.67 - $7.18
52 week range
$2.44 - $8.84
Volume
515
Avg. Volume (30 days)
150,409
Market Cap
$353.08M
Dividend Yield
-
P/E
-
Shares Outstanding
50,154,073
Open
-
Previous Close
$6.59
Days Range
$6.67 - $7.18
52 week range
$2.44 - $8.84
Volume
515
Avg. Volume (30 days)
150,409
Market Cap
$353.08M
Dividend Yield
-
P/E
-
Shares Outstanding
50,154,073
FINANCIAL STATEMENTS FOR MONTE ROSA THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR MONTE ROSA THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Yang Rick10% OwnerJun 28, 2021 Buy$19.001,050,00019,950,0007,692,298Jun 30, 2021, 06:09 PM
Walker Paul Edward10% OwnerJun 28, 2021 Buy$19.001,050,00019,950,0007,692,298Jun 30, 2021, 06:08 PM
Sonsini Peter W.10% OwnerJun 28, 2021 Buy$19.001,050,00019,950,0007,692,298Jun 30, 2021, 06:08 PM
SANDELL SCOTT D10% OwnerJun 28, 2021 Buy$19.001,050,00019,950,0007,692,298Jun 30, 2021, 06:07 PM
Mathers Edward T10% OwnerJun 28, 2021 Buy$19.001,050,00019,950,0007,692,298Jun 30, 2021, 06:06 PM
MAKOWER JOSHUA10% OwnerJun 28, 2021 Buy$19.001,050,00019,950,0007,692,298Jun 30, 2021, 06:06 PM
Makhzoumi Mohamad10% OwnerJun 28, 2021 Buy$19.001,050,00019,950,0007,692,298Jun 30, 2021, 06:05 PM
Landsman Liza10% OwnerJun 28, 2021 Buy$19.001,050,00019,950,0007,692,298Jun 30, 2021, 06:04 PM
Florence Anthony A. Jr.10% OwnerJun 28, 2021 Buy$19.001,050,00019,950,0007,692,298Jun 30, 2021, 06:02 PM
Chang Carmen10% OwnerJun 28, 2021 Buy$19.001,050,00019,950,0007,692,298Jun 30, 2021, 06:02 PM
Behbahani AliDirectorJun 28, 2021 Buy$19.001,050,00019,950,0007,692,298Jun 30, 2021, 06:01 PM
BASKETT FOREST10% OwnerJun 28, 2021 Buy$19.001,050,00019,950,0007,692,298Jun 30, 2021, 06:00 PM
New Enterprise Associates 17, L.P.10% OwnerJun 28, 2021 Buy$19.001,050,00019,950,0007,692,298Jun 30, 2021, 05:59 PM
Bolzon Bradley J PhDDirectorJun 28, 2021 Buy$19.00157,8953,000,0052,097,938Jun 30, 2021, 05:05 PM
Versant Venture Capital VI, L.P.10% OwnerJun 28, 2021 Buy$19.00157,8953,000,0052,097,938Jun 30, 2021, 05:00 PM
Cormorant Asset Management, LPFormer 10% OwnerJun 28, 2021 Buy$19.00600,00011,400,0003,202,200Jun 30, 2021, 04:08 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Yang Rick10% Owner06/28/202119,950,000
Walker Paul Edward10% Owner06/28/202119,950,000
Sonsini Peter W.10% Owner06/28/202119,950,000
SANDELL SCOTT D10% Owner06/28/202119,950,000
Mathers Edward T10% Owner06/28/202119,950,000
MAKOWER JOSHUA10% Owner06/28/202119,950,000
Makhzoumi Mohamad10% Owner06/28/202119,950,000
Landsman Liza10% Owner06/28/202119,950,000
Florence Anthony A. Jr.10% Owner06/28/202119,950,000
Chang Carmen10% Owner06/28/202119,950,000
Behbahani AliDirector06/28/202119,950,000
BASKETT FOREST10% Owner06/28/202119,950,000
New Enterprise Associates 17, L.P.10% Owner06/28/202119,950,000
Bolzon Bradley J PhDDirector06/28/20213,000,005
Versant Venture Capital VI, L.P.10% Owner06/28/20213,000,005
Cormorant Asset Management, LPFormer 10% Owner06/28/202111,400,000
Load More Insider Transactions
FUNDS WITH A POSITION IN MONTE ROSA THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BAKER BROS. ADVISORS LP4,916,0950.32%No changeOther
BLACKROCK INC.2,371,9800.00034%-35.8%Other
GEODE CAPITAL MANAGEMENT, LLC687,6710.00041%6.21%Other
CANDRIAM S.C.A.135,0000.00526%No changeOther
RENAISSANCE TECHNOLOGIES LLC105,2000.00092%14.97%Other
UBS OCONNOR LLC44,2470.02%-48.24%Value
BALYASNY ASSET MANAGEMENT L.P.38,8020.00041%NewEvent Driven
CHANGE IN SHARES OUTSTANDING FOR MONTE ROSA THERAPEUTICS INC
STOCK BUYBACKS FOR MONTE ROSA THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
14.40%
1Q
12/31/2023
06/30/2023
15.29%
2Q
12/31/2023
03/31/2023
15.48%
3Q
12/31/2023
12/31/2022
16.51%
4Q
12/31/2023
09/30/2022
21.95%
5Q
12/31/2023
06/30/2022
22.11%
6Q
12/31/2023
03/31/2022
22.30%
7Q
12/31/2023
09/30/2021
23.92%
9Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
14.40%
1Q
06/30/2023
15.29%
2Q
03/31/2023
15.48%
3Q
12/31/2022
16.51%
4Q
09/30/2022
21.95%
5Q
06/30/2022
22.11%
6Q
03/31/2022
22.30%
7Q
09/30/2021
23.92%
9Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR MONTE ROSA THERAPEUTICS INC
LOADING...